Topics

Alkermes Presents New Health Economics and Outcomes Research on Patients With Schizophrenia and Bipolar I Disorder at 2019 Psych Congress

07:01 EDT 7 Oct 2019 | FinanzNachrichten

-- Findings From Patient Surveys Underscore Need for New Antipsychotic Treatments With Reduced Side Effects -- DUBLIN, Oct. 7, 2019 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced the ...

Original Article: Alkermes Presents New Health Economics and Outcomes Research on Patients With Schizophrenia and Bipolar I Disorder at 2019 Psych Congress

NEXT ARTICLE

More From BioPortfolio on "Alkermes Presents New Health Economics and Outcomes Research on Patients With Schizophrenia and Bipolar I Disorder at 2019 Psych Congress"

Quick Search